Nano Dimension Ltd. (NNDM), a leader in the area of 3D printed electronics, uplisted its American Depositary Shares (ADSs) to the NASDAQ Capital Market under the symbol “NNDM,” effective on March 7, 2016. Nano Dimension’s ordinary shares also trade on the Tel Aviv Stock Exchange.
March, 2016
A ZAG-S&W Team represented Cellect Biotechnology Ltd. in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs.
The gross proceeds to Cellect from this offering are $8.4 million.
July, 2016
Attornyes Oded Har-Even, Shy Baranov, Robert Condon, David Huberman and Hila Nahum represented the company as issuer's counsel in a certain registered direct offering for an aggregate price of $6.7M. Roth Capital and Rodman & Renshaw acted as co-placement agents for the offering.
March, 2016
Attorneys Oded Har-Even, Rob Condon and Hila Nahum represented the Bank on a public offdering of VistaGen Therapeutics, a biomed company that develops products for the treatment of diseases related to the nervous system.
May, 2016
Aegis Capital Corp. is an investment bank and underwriter. Rennova Health's common stock and warrants are listed on the NASDAQ Capital Market.
December, 2015
Attorneys Oded Har-Even, Howard Berkenblit, Rob Condon and Ron Ben Bassat represented the company.
July, 2016
Attorneys Oded Har-Even, Rob Condon, Hila Nahum, Jene Schlack and Ron Ben-Bassat, represented Gunner & Joseph who served as an underwriter in the offering.
July, 2016
The team includud Oded Har-Even, Robert Condon, Ron Ben Bassat and Leigh Sapir-Kashi. Roth Capital Partners acted as the lead placement agent and Maxim Group LLC acted as the co-placement agent for this transaction.
September, 2016
Attorrneys Oded Har-Even and Robert Condon at the annual conference.
12.9.2016
The ZAG-S&W team included Oded Har-Even, Howard Berkenblit, Rob Condon, Shy Baranov, David Huberman, Ron Ben-Bassat and Hila Nahum.
September, 2016
The Legal 500 United States recommended Sullivan & Worcester in 14 of its practice areas and noted 36 of its lawyers in the 2016 edition. June 15, 2016
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics, which develops and commercializes a full range of microRNA-based and other molecular diagnostics.
December, 2016
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $12.4 million private placement offering of preferred shares By Rennova Health Inc.
December, 2016
Attornyes Oded Har-Even, Rob Condon and Hila Nahum represented Roth Capital.
December, 2016
Attornyes Oded Har-Even, Ron Ben-Bassat and Robert Condon represented DarioHealth Corp. in the private placement.
The deal was led by OurCrowd Qure, a dedicated digital health fund.
January, 2017
Advs. Oded Har-Even, Rob Condon and Ron Ben-Bassat from the American Capital Markets departmemt at the firm represented the company in a private placement on Nasdaq
Globes, 15.1.2017
This Client Advisory discusses the key securities provisions of the recently enacted FAST Act, and its impact on emerging growth companies, disclosure requirements for reporting companies, resales of unregistered securities and the registration process for smaller reporting companies. (PDF)